Medpace Holdings, Inc.MEDPNASDAQ
Loading
P/FCF Ratio Over TimeExpanding
Percentile Rank92
3Y CAGR+6.6%
5Y CAGR+1.7%
Studio
Year-over-Year Change

Price to free cash flow ratio

3Y CAGR
+6.6%/yr
vs +10.0%/yr prior
5Y CAGR
+1.7%/yr
Recent acceleration
Acceleration
-3.3pp
Decelerating
Percentile
P92
Near historical high
vs 5Y Ago
1.1x
Modest growth
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
202523.76+32.2%
202417.97-24.3%
202323.74+21.2%
202219.59-41.0%
202133.20+52.2%
202021.82+33.1%
201916.40+22.5%
201813.39-19.6%
201716.64+1.1%
201616.46-